Reboxetine and combination therapy with AD128 in sleep apnoea trial: A double-blind, 3-way cross-over study
Latest Information Update: 12 Oct 2021
At a glance
- Drugs Oxybutynin/reboxetine combination therapy-Apnimed (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- Acronyms ReboxOSA
Most Recent Events
- 08 Oct 2021 Status changed from recruiting to completed.
- 23 Jun 2020 Status changed from not yet recruiting to recruiting.
- 16 Jun 2020 New trial record